Risk Factors of Tuberculosis Destroyed Lung in Patients with Pulmonary Tuberculosis and Structural Lung Diseases: A Retrospective Observational Study

Overview

Journal Risk Manag Healthc Policy

Publisher Dove Medical Press

Specialty Public Health

Date 2024 Apr 3

PMID 38567384

Authors

Linlin Liu

Xiufen Wang

Li Luo

Xuhui Liu

Jingfang Chen

Affiliations

Soon will be listed here.

Abstract

Background: Tuberculosis destroyed lung constitutes a significant worldwide public health challenge, little is known about its associated risk factors and prognosis. Our study aimed to identify the risk factors of tuberculosis destroyed lung among pulmonary tuberculosis and structural lung diseases.

Methods: Between January 2019 and December 2021, a case-control study was conducted at the Third People's Hospital of Shenzhen in China. We collected the clinical data among patients with pulmonary tuberculosis and structural lung diseases. Cases were defined as patients with tuberculosis destroyed lung. Controls were not diagnosed with the tuberculosis destroyed lung. A binary logistic regression was performed.

Results: In our study, a total of 341 patients met the inclusion criteria, including 182 cases and 159 controls. We found that age ranges of 46-60 years (aOR: 4.879; 95% CI: 2.338-10.180), >60 years (aOR: 3.384; 95% CI: 1.481-7.735); history of TB treatment (aOR: 2.729; 95% CI: 1.606-4.638); malnutrition (aOR: 5.126; 95% CI: 1.359-19.335); respiratory failure (aOR: 5.080; 95% CI: 1.491-17.306); and bronchiarctia (aOR: 3.499; 95% CI: 1.330-9.209) were the independent risk factors for tuberculosis destroyed lung. Conversely, having a normal (aOR: 0.207; 95% CI: 0.116-0.371) or overweight BMI (aOR: 0.259; 95% CI: 0.090-0.747) emerged as a protective factor against tuberculosis destroyed lung.

Conclusion: This study indicated that tuberculosis destroyed lung is a common condition among patients with pulmonary tuberculosis and structural lung diseases. The independent risk factors for tuberculosis destroyed lung were identified as being within the age groups of 46-60 and over 60 years, having a previous history of TB treatment, malnutrition, respiratory failure, and bronchiarctia. It is essential to closely monitor patients possessing these risk factors to prevent the progression towards tuberculosis destroyed lung.

Citing Articles

Nutritional Factors and Food and Nutrition Insecurity in Patients with Tuberculosis.

Mendes Y, Dourado A, de Oliveira P, Rezende A, Sales A, de Sousa G Nutrients. 2025; 17(5).

PMID: 40077748 PMC: 11901461. DOI: 10.3390/nu17050878.

References

Hnizdo E, Singh T, Churchyard G . Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 1999; 55(1):32-8. PMC: 1745584. DOI: 10.1136/thorax.55.1.32. View

Ravimohan S, Kornfeld H, Weissman D, Bisson G . Tuberculosis and lung damage: from epidemiology to pathophysiology. Eur Respir Rev. 2018; 27(147). PMC: 6019552. DOI: 10.1183/16000617.0077-2017. View

Jo Y, Park J, Lee J, Heo E, Chung H, Kim D . Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017; 12:2433-2443. PMC: 5565253. DOI: 10.2147/COPD.S136304. View

Wang X, Luo L, Zhang D, Wang J, Ning X, Lin Y . Factors Associated with Nutritional Risk in Patients with Pulmonary Tuberculosis and Structural Lung Disease: A Hospital-Based Cross-Sectional Study. J Multidiscip Healthc. 2022; 15:1799-1807. PMC: 9426578. DOI: 10.2147/JMDH.S375441. View

Sarkar M, Srinivasa , Madabhavi I, Kumar K . Tuberculosis associated chronic obstructive pulmonary disease. Clin Respir J. 2017; 11(3):285-295. DOI: 10.1111/crj.12621. View

Middelkoop K, Bekker L, Shashkina E, Kreiswirth B, Wood R . Retreatment tuberculosis in a South African community: the role of re-infection, HIV and antiretroviral treatment. Int J Tuberc Lung Dis. 2012; 16(11):1510-6. PMC: 3819504. DOI: 10.5588/ijtld.12.0049. View

Lee J, Chang J . Lung function in patients with chronic airflow obstruction due to tuberculous destroyed lung. Respir Med. 2003; 97(11):1237-42. DOI: 10.1016/s0954-6111(03)00255-5. View

Kim S, Lee J, Park Y, Lee C, Lee S, Yim J . Effect of airflow limitation on acute exacerbations in patients with destroyed lungs by tuberculosis. J Korean Med Sci. 2015; 30(6):737-42. PMC: 4444474. DOI: 10.3346/jkms.2015.30.6.737. View

Hoyt K, Sarkar S, White L, Joseph N, Salgame P, Lakshminarayanan S . Effect of malnutrition on radiographic findings and mycobacterial burden in pulmonary tuberculosis. PLoS One. 2019; 14(3):e0214011. PMC: 6436704. DOI: 10.1371/journal.pone.0214011. View

10.

Putri F, Burhan E, Nawas A, Soepandi P, Sutoyo D, Agustin H . Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia. Int J Tuberc Lung Dis. 2014; 18(5):564-70. DOI: 10.5588/ijtld.13.0602. View

11.

Bongomin F . Post-tuberculosis chronic pulmonary aspergillosis: An emerging public health concern. PLoS Pathog. 2020; 16(8):e1008742. PMC: 7440622. DOI: 10.1371/journal.ppat.1008742. View

12.

Malherbe S, Dupont P, Kant I, Ahlers P, Kriel M, Loxton A . A semi-automatic technique to quantify complex tuberculous lung lesions on F-fluorodeoxyglucose positron emission tomography/computerised tomography images. EJNMMI Res. 2018; 8(1):55. PMC: 6020088. DOI: 10.1186/s13550-018-0411-7. View

13.

Lin Y, Liu Y, Zhang G, Cai Q, Hu W, Xiao L . Is It Feasible to Conduct Post-Tuberculosis Assessments at the End of Tuberculosis Treatment under Routine Programmatic Conditions in China?. Trop Med Infect Dis. 2021; 6(3). PMC: 8482211. DOI: 10.3390/tropicalmed6030164. View

14.

Kim C, Yoon H, Park M, Yoo K, Jung K, Park J . Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study. Int J Chron Obstruct Pulmon Dis. 2017; 12:1589-1596. PMC: 5459963. DOI: 10.2147/COPD.S128750. View

15.

Birlie A, Tesfaw G, Dejene T, Woldemichael K . Time to Death and Associated Factors among Tuberculosis Patients in Dangila Woreda, Northwest Ethiopia. PLoS One. 2015; 10(12):e0144244. PMC: 4687639. DOI: 10.1371/journal.pone.0144244. View

16.

Blyth D . Pneumonectomy for inflammatory lung disease. Eur J Cardiothorac Surg. 2000; 18(4):429-34. DOI: 10.1016/s1010-7940(00)00526-1. View

17.

Araujo G, Pereira S, Neves Dos Santos D, Marinho J, Rodrigues L, Barreto M . Common mental disorders associated with tuberculosis: a matched case-control study. PLoS One. 2014; 9(6):e99551. PMC: 4061008. DOI: 10.1371/journal.pone.0099551. View

18.

Ruan H, Liu F, Han M, Gong C . Incidence and risk factors of postoperative complications in patients with tuberculosis-destroyed lung. BMC Pulm Med. 2021; 21(1):273. PMC: 8380317. DOI: 10.1186/s12890-021-01641-0. View

19.

Fawibe A, Salami A, Oluboyo P, Desalu O, Odeigha L . Profile and outcome of unilateral tuberculous lung destruction in Ilorin, Nigeria. West Afr J Med. 2011; 30(2):130-5. View

20.

Menzies N, Quaife M, Allwood B, Byrne A, Coussens A, Harries A . Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae. Lancet Glob Health. 2021; 9(12):e1679-e1687. PMC: 8609280. DOI: 10.1016/S2214-109X(21)00367-3. View